Does hypothalamic-pituitary-adrenal axis hypofunction in chronic fatigue syndrome reflect a 'crash' in the stress system?
Van Houdenhove, Boudewijn, Van Den Eede, Filip, Luyten, Patrick · Medical hypotheses · 2009 · DOI
Quick Summary
This study explores why many ME/CFS patients have problems with their stress hormone system, particularly a gland in the brain called the hypothalamus. The researchers suggest that ME/CFS might involve a breakdown in how the body normally responds to stress, leading to an imbalance that triggers excessive inflammation and sickness symptoms like exhaustion and pain sensitivity.
Why It Matters
Understanding the mechanisms behind HPA axis dysfunction could help clinicians recognize ME/CFS as a distinct neuroendocrine-immune disorder and move beyond viewing it as primarily psychological. If validated, this framework could direct research toward the immune-endocrine interface and inform development of mechanism-targeted therapies rather than generic fatigue treatments.
Observed Findings
HPA axis hypofunction is documented in a substantial proportion of CFS patients
Disturbed balance between glucocorticoid and inflammatory signaling pathways is hypothesized to occur in CFS
Cytokine-induced sickness responses may underlie effort/stress intolerance and pain hypersensitivity
Persistent dysregulation of the neurobiological stress system appears characteristic of the illness
Inferred Conclusions
HPA axis dysfunction in CFS reflects fundamental stress system dysregulation rather than isolated neuroendocrine failure
Cytokine-mediated sickness response represents a potential final common pathway for central CFS symptoms
The neuroendocrine-immune interface warrants focused investigation as a key disease mechanism
Histories of early and recent life stress may contribute to HPA axis dysregulation in CFS
Remaining Questions
Does HPA axis hypofunction in CFS directly cause symptoms, or is it a consequence of other primary pathological processes?
What specific triggers or mechanisms initiate and perpetuate stress system dysregulation in susceptible individuals?
What This Study Does Not Prove
This theoretical review does not establish causation or present new experimental evidence—it synthesizes existing literature and proposes a hypothesis. The study cannot definitively prove that HPA dysfunction causes ME/CFS symptoms or explain the relative contributions of stress system dysregulation versus other potential pathogenic factors. The authors acknowledge uncertainty about whether neuroendocrine disturbances are primary drivers or secondary consequences of illness.